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Interventional Cardiologists Suffer an Excessive
Incidence of Spinal Disc Disease
Placebo c7E3Fab
Ionic Non-ionic Ionic Non-ionic
Outcome (n = 257) (n = 380) In = 505) In = 788)
Post-PTCA thrombus (%) 17 18 15 15
Q-wave MI (%)+ 1.6 32 0.2 1.4
Emergent CABG 1%)+ 2.7 4.5 2.0 2.5
Death (%)+ 0.4 1.6 0.4 1.4
Allan M. Ross, David Borenstein, Ellen Jenkins, Shyuan Cho, Jerome Segal. The
George Washington University, Washington, DC
Back and neck pain are common complaints and frequent reasons for
workdays lost amongst interventional cardiologists (Card) but neither an in-
creased frequency of spinal skeletal problems within this specialty nor its
presumed relationship to radiation shielding lead aprons has been previ-
ously verified. We mailed surveys to 875 interventional cardiologists (who
performed an average of 12.1 ± 7.4 procedures per week) and for compari-
son, mailed 595 surveys to orthopods (who spend long hours standing, but
without wearing lead) and 990 rheumatologists (with neither "risk factor").
Since the data on the latter 2 groups did not differ, they are combined as
"controls." The overall survey response was 30%.
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Previous studies have demonstrated greater thrombogenic properties and
higher rates of post-PTCA ischemic complications with use of non-ionic (NI)
compared to ionic (I) contrast media. To assess the role of I vs NI contrast
media on thrombus formation and ischemic complications, we prospectively
evaluated the post-PTCA outcome of 1,930 patients who were enrolled in
the EPIC trial. Patients were enrolled if presenting with acute MI (:s7 days),
unstable angina, or had high risk angiographic characteristics. Patients re-
ceived aspirin (325 mg), procedural heparin, and either placebo infusion (n
= 637) or a glycoprotein IIB/IIIA receptor antibody, c7E3Fab (n = 1293). I and
NI were used in 257 and 380 patients receiving placebo and in 505 and 708
patients receiving c7E3Fab, respectively. More patients receiving NI were
enrolled with acute MI (3.5% vs 1.4%), and more patients receiving I had
unstable angina (26.1 % vs 22.4%). Other baseline and procedural character-
istics were similar between patient groups.
+ in-hospital; MI :::: myocardial infarction; CABG = coronary bypass surgery
Interestingly, we found a predominance of cervical and not low back com-
plaints by interventionalists, although combined upper and lower spine com-
plaints (multiple levels) were more common in the cardiology group. Con-
clusion: Long hours spent performing procedures while wearing radiation-
shielding lead aprons (which are purported to produce >300 pounds per
square inch of intervertebral disc pressure), induces a distinct occupational
hazard, "interventional cardiologist's disc disease".
Impact of Ionic and Non-ionic Contrast Media on
Post-PTCA Ischemic Complications: Results from
the EPIC Trial
After controlling for c7E3Fab randomization by logistic regression, ionic
contrast agents were associated with a lower probability of O-wave MI (odds
ratio: 0.32; p = 0.012) and death (odds ratio: 0.27; p = 0.016). These pre-
liminary data suggest that the selection of ionic contrast media during PTCA
should strongly be considered.
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Interstate Variability of Rates of Percutaneous
Transluminal Coronary Angioplasty in the United
States Medicare Population
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Initial experimental and clinical studies have shown that cardiomyoplasty us-
ing the right latissimus dorsi can improve left ventricular (LV) function early
after operation. This study presents the long-term results of clinical appli-
cation of this procedure. Between March 1991 and November 1992, 16 pa-
tients (12 men, 4 women; mean age 57; range 33-77 years) underwent op-
eration. Survivors have now been followed for 18 months with serial right
heart catheterization and radionuclide angiography at 6 month intervals. The
operative mortality was 6% (1/16), but 3 additional patients experienced sud-
den death within 6 months of operation. Survival was 62.5% (10/16) at 12
months and 56.3% (9/16) at 18 months. The LV stroke work index (LVSWI)
was improved at each postoperative interval, but the differences were not
statistically significant. Left ventricular ejection fraction (LVEF) significantly
increased from 26.1 ± 5.3 to 33.4 ± 10.3 (p < 0.05), 6 weeks after opera-
tion and was not different from baseline thereafter. The LV end-diastolic vol-
ume decreased significantly at 6 months from 306.1 ± 71 to 249.4 ± 69 mL
(p < 0.01), and remained lower than the preoperative value in subsequent
follow-up. Comparison of preoperative LVEF in 24 month survivors (51 and
non-survivors (8) revealed that survivors had an LVEF of 30.2 ± 4.38 and non-
survivors were 22.7 ± 2.58 (p < 0.05). Preoperative LVSWI was also signifi-
cantly greater in survivors 36.4 ± 6.91 gm-cm/m2 vs 20.1 ± 8.26 gm-cm/m 2 ,
(p < 0.05). Overall survival was limited by the occurrence of sudden death,
but survivors had improved functional capacity and stabilization of cardiac
size and function. We conclude that careful selection of patients with better
preserved, preoperative LV function may yield improved long-term survival
in right latissimus cardiomyoplasty.
ANGIOPLASTY - CONVENTIONAL
8A
Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures are
commonly performed in the United States (US) for the invasive management
of coronary artery disease (CAD). Because of the relative expense and fre-
quency of PTCA and increasingly elderly US population, the annual health
care expenditure for PTCA is significant and will continue to expand. The clin-
ical indications for PTCA have been fairly well-established. Our study tested
the hypothesis that the incidence of PTCA per State was constant. We exam-
ined the 1992 PTCA database from the Health Care Financing Administration
(HCFA) which included procedure volume for 805 US hospitals performing
PTCA on Medicare patients and was aggregated by State. Population data
for age >65 was obtained for each State from the US Census Bureau for
1990. We found a significant variability in PTCA rates per 100,000 population
age >65 (PTCA/l00,000) ranging from 89 to 831. For the 10 States with the
largest population age >65, the PTCA/I00,000 ranged from 130 to 503. As
the number of programs (per 100,000 age >65) increased, the PTCA/l 00,000
increased (r2 = 0.40; P < 0.0001) (A). This was also observed for the 10
largest States and was highly significant (r2 = 0.71; P = 0.002) (B). Low
rates of PTCA/l 00,000 were associated with Certificate of Need programs.
We conclude that: 1) PTCA/l 00,000 varies considerably from State to State
despite established indications, 2) Certificate of Need programs may reduce
PTCA/I00,000 rates, and 3) investigation into the appropriateness of PTCA
should be performed on an individual statewide basis.
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